Up to 50% of patients with depression do not adequately respond to standard antidepressant therapy, resulting in treatment-resistant depression (TRD), for which lithium and quetiapine are common augmentation strategies. Atypical depression, characterised by mood reactivity and reversed neurovegetative symptoms, is a cl...
G. Ingrosso, S. Masier, A. D'Agostino et al.· Psychiatry Research· 0 citations
Atypical depression was first described in the 1950s, but after a surge of interest and publications in the 1980s, this construct appears to have fallen out of focus, with comparatively less literature produced over recent decades. Despite different conceptualisations proposed by different authors, atypical depression...
G. Ingrosso, A. Cleare· Frontiers in Psychiatry· 0 citations
Abstract Background Treatment-resistant depression (TRD) affects up to half of patients with major depressive disorder and is associated with poorer health outcomes. Lithium and quetiapine are established augmentation strategies in cases of TRD, but there is limited evidence to inform treatment choice in different depr...
G. Ingrosso, S. Masier, A. D'Agostino et al.· International Journal of Neu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
